Search for: "Bristol, Inc." Results 301 - 320 of 509
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Aug 2013, 10:44 am by John Lewis
Bristol Care, Inc., 702 F.3d 1050, 1052-53 (2013), which stated: “ . . . if an employee must affirmatively optin to any such class action, surely the employee has the power to waive participation in a class action as well. [read post]
7 Jun 2007, 4:29 pm
Ortega Construction, Inc. (21-CA-37055, 37167, and 21-RC-20823; 349 NLRB No. 105) San Diego, CA May 21, 2007. [read post]
6 Jan 2007, 7:34 am
"  For example, "the venom of a deadly sea snail found off the coast of the Philippines led Elan Pharmaceuticals Inc. to develop the painkiller Prialt, which U.S. regulators approved in 2004. [read post]
17 May 2022, 6:18 am by The White Law Group
    The claim further alleges that Concord Investment Services unsuitably invested its clients in the following high-risk alternative investments, among others:   VII Peaks Co-Optivist Income BDC II, Inc. [read post]
7 Jun 2007, 1:55 am
What constitutes patentable second medical use is occasionally a subject of dispute, a neat example being Actavis UK Ltd v Merck & Co Inc [2007] EWHC 1311 (Ch), an English Patents Court decision from Mr Justice Warren yesterday, available here on BAILII. [read post]
26 Feb 2013, 9:02 am by Pilar G. Kraman
stubid=20311 Testimonials: "Excellent overviews of AIA from those who wrote it, those who will implement it, and those who must live with it" - Graham Douglas, IDDEX (2012) "Assessments and points of view you won't find any place else" - Jim Farmer, Georgetown University (2012) You will network with: Accuray Inc, Americas Bankers Association, Boeing Company, CIENA, Department of Homeland Security, Eldelman, El Cap Ventures, Eli Lilly & Company, Embassy of Canada, Emergent… [read post]
7 Mar 2012, 4:47 pm
A quick search reveals that this phrase had been previously used by Sir Robin in Leo Pharma A/S v Sandoz Ltd, [2009] EWCA Civ 1188 and before that in Bristol Myers Squibb Co v Baker Norton Pharmaceuticals Inc, [1999] RPC 253. [read post]
28 May 2008, 8:56 am
According to a survey by Treasury Strategies Inc., corporations owned $98 billion of the securities on Jan. 1. [read post]
24 Nov 2010, 12:37 am by Kelly
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
4 Sep 2012, 7:31 am by arester
But as she prepared to woo drug maker Amylin Pharmaceuticals Inc. last year, she was worried. [read post]
18 Feb 2020, 4:00 am by Martin Kratz
Pfizer Canada ULC, 2020 FC 1, at para. 48. [12] See Free World Trust, supra, at paragraph 13; Apotex Inc v Wellcome Foundation Ltd, 2002 SCC 77 at paragraph 37, [2002] 4 SCR 153; AstraZeneca Canada Inc v Apotex Inc, 2017 SCC 36 at paragraph 39, [2017] 1 SCR 943 [13] See Free World Trust, supra, at paragraphs 33–43; applied in Seedlings Life Science Ventures, LLC v. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]